gadolinium has been researched along with n-caproylsphingosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiji, MM; Cacaccio, J; Coleman, TP; Davis, BJ; Ganta, S; Patel, NR; Rawal, YH; Singh, A | 1 |
| Amiji, MM; Coleman, TP; Davis, B; Ferris, C; Ganta, S; Keeler, AW; Kulkarni, P; O'Neal, S; Patel, NR; Piroyan, A; Sawant, RR; Singh, A; Zamboni, W | 1 |
2 other study(ies) available for gadolinium and n-caproylsphingosine
| Article | Year |
|---|---|
Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer.
Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Ceramides; Drug Carriers; Drug Delivery Systems; Emulsions; Female; Gadolinium; Green Fluorescent Proteins; Humans; Magnetic Resonance Imaging; Molecular Sequence Data; Organoplatinum Compounds; Ovarian Neoplasms; Ovary; Peptides | 2014 |
EGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Blood Platelets; Ceramides; Drug Delivery Systems; ErbB Receptors; Female; Gadolinium; Mice; Microfluidics; Organoplatinum Compounds; Ovarian Neoplasms; Particle Size; Survival Analysis; Theranostic Nanomedicine; Tissue Distribution | 2015 |